✅국감서 제기된 '싸이모신알파1' 재평가 필요하나

https://www.dailypharm.com/Users/News/NewsView.html?ID=327961

✅임신중지약 허가 급물살 타나…비만주사제 오남용 도마

https://www.dailypharm.com/Users/News/NewsView.html?ID=327922

✅성장호르몬제 온라인 불법유통 게시물 등 219건 적발

https://www.dailypharm.com/Users/News/NewsView.html?ID=327941

✅"레켐비 부작용 후속조치 없어...식약처 허가·사후관리 불신"

https://www.dailypharm.com/Users/News/NewsView.html?ID=327908

✅"신약R&D 약가우대책 마련…외국약가·급여재평가는 검토"

https://www.dailypharm.com/Users/News/NewsView.html?ID=327970

✅"이중약가제 확대 추진...혁신신약 도입 리스크 해소"

https://www.dailypharm.com/Users/News/NewsView.html?ID=327925